Eris Lifesciences Appoints Akhil Awasthi as Independent Director for Five-Year Term
Eris Lifesciences Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 2:41 pm
Eris Lifesciences Appoints Akhil Awasthi as Independent Director for Five-Year Term Eris Lifesciences approved the appointment of Mr. Akhil Awasthi as an Additional Director (Non-Executive, Independent) for a five-year term, effective 26th Sep'26, subject to shareholder approval. Mr. Awasthi brings over 30 years of experience across private equity, healthcare, lifesciences, and corporate governance. His background includes leadership roles as Founding Managing Partner at Tata Capital Growth Fund and Partner at Baring Private Equity Partners (India). He holds no familial ties to existing directors and faces no regulatory debarment from holding board positions.
Original exchange filing (PDF)
More announcements from Eris Lifesciences Ltd
- as attached 路 13 Nov 2026
- The Company will host "Eris Investor Meet - 2026" on November 19, 2026 路 29 Oct 2026
- as attached 路 29 Oct 2026
- as attached 路 27 Oct 2026
- as attached 路 26 Oct 2026
- as attached 路 26 Oct 2026
- as attached 路 26 Oct 2026
- Eris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 26 Oct 2026
